Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Gesellschaft für Epilepsieforschung (GfE) is a specialized German research organization dedicated to advancing the diagnosis and treatment of epilepsy. Based in Bielefeld-Bethel, the institute operates as a clinical research center that conducts Phase I through IV clinical trials for investigational anti-seizure medications and medical devices. GfE provides a comprehensive suite of services including pharmacokinetics, long-term EEG monitoring, and neuropsychological testing to evaluate therapeutic outcomes. The organization maintains a close partnership with the Bethel Epilepsy Center and the Mara Hospital, ensuring a strong link between academic research and clinical patient care. Its work contributes significantly to the development of international guidelines for epilepsy management and the regulatory approval of new neurological therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gesellschaft für Epilepsieforschung.